Marc Baguelin

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. doi request reprint Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
    Marc Baguelin
    Centre for Infections, Health Protection Agency, United Kingdom
    Vaccine 28:2370-84. 2010
  2. pmc Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation
    Marc Baguelin
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 6:e17074. 2011
  3. pmc Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011
    Katja Hoschler
    Respiratory Virus Unit, Virus Reference Department, Microbiology Services Colindale, Health Protection Agency, 61 Colindale Ave, London, NW9 5HT, UK
    Emerg Infect Dis 18:1894-7. 2012
  4. doi request reprint Health and economic impact of the seasonal influenza vaccination programme in England
    Marc Baguelin
    Health Protection Agency, United Kingdom
    Vaccine 30:3459-62. 2012
  5. doi request reprint The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
    Mark Jit
    Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:115-22. 2010
  6. pmc Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study
    Marc Baguelin
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
    PLoS Med 10:e1001527. 2013
  7. doi request reprint Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries
    Stefan Flasche
    Centre for Infections, Health Protection Agency, London, UK
    Epidemics 3:125-33. 2011

Collaborators

Detail Information

Publications7

  1. doi request reprint Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
    Marc Baguelin
    Centre for Infections, Health Protection Agency, United Kingdom
    Vaccine 28:2370-84. 2010
    ..In countries where the epidemic is not so far advanced vaccination of children may be cost-effective. Similar, detailed, real-time modelling and economic studies could help to clarify the situation...
  2. pmc Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation
    Marc Baguelin
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 6:e17074. 2011
    ..The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period...
  3. pmc Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011
    Katja Hoschler
    Respiratory Virus Unit, Virus Reference Department, Microbiology Services Colindale, Health Protection Agency, 61 Colindale Ave, London, NW9 5HT, UK
    Emerg Infect Dis 18:1894-7. 2012
    ..Population-based seroepidemiology confirms that the third wave of influenza A(H1N1)pdm09 virus circulation was associated with a shift in age groups affected, with the highest rate of infection in young adults...
  4. doi request reprint Health and economic impact of the seasonal influenza vaccination programme in England
    Marc Baguelin
    Health Protection Agency, United Kingdom
    Vaccine 30:3459-62. 2012
    ..The seasonal influenza vaccination programme in England targets individuals over 65 years old and in clinical risk groups...
  5. doi request reprint The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
    Mark Jit
    Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:115-22. 2010
    ..Key sources of uncertainty are the cost of vaccine delivery and the quality of life detriment due to a clinically apparent episode of confirmed influenza. The cost of vaccine purchase itself is relatively low...
  6. pmc Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study
    Marc Baguelin
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
    PLoS Med 10:e1001527. 2013
    ..We developed methods to synthesise the multiplicity of surveillance datasets in order to evaluate how changing target populations in the seasonal vaccination programme would affect infection rate and mortality...
  7. doi request reprint Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries
    Stefan Flasche
    Centre for Infections, Health Protection Agency, London, UK
    Epidemics 3:125-33. 2011
    ..However, much uncertainty remains. With better information on the role of these epidemiological factors, the control of influenza could be improved...